MedTrace Logo

A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol Formulations

NCT01568749 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2014-11-24

No results posted yet for this study

Summary

A study investigating the pharmacokinetic profiles of four extended release paracetamol formulations

Conditions

  • Analgesia

Interventions

DRUG

Paracetamol

Paracetamol

DRUG

Paracetamol formulation 1

Paracetamol

DRUG

Paracetamol Formulation 2

Paracetamol

DRUG

Paracetamol formulation 3

Paracetamol

DRUG

Paracetamol formulation 4

paracetamol

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01568749 on ClinicalTrials.gov